Literature DB >> 18329019

Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease.

Samer D Tabbal1, Mwiza Ushe, Jonathan W Mink, Fredy J Revilla, Angie R Wernle, Minna Hong, Morvarid Karimi, Joel S Perlmutter.   

Abstract

BACKGROUND: Bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves motor function in Parkinson disease (PD). However, little is known about the quantitative effects on motor behavior of unilateral STN DBS.
METHODS: In 52 PD subjects with STN DBS, we quantified in a double-blinded manner rigidity (n=42), bradykinesia (n=38), and gait speed (n=45). Subjects were tested in four DBS conditions: both on, left on, right on and both off. A force transducer was used to measure rigidity across the elbow, and gyroscopes were used to measure angular velocity of hand rotations for bradykinesia. About half of the subjects were rated using the Unified Parkinson Disease Rating Scale (part III) motor scores for arm rigidity and repetitive hand rotation simultaneously during the kinematic measurements. Subjects were timed walking 25 feet.
RESULTS: All subjects had significant improvement with bilateral STN DBS. Contralateral, ipsilateral and bilateral stimulation significantly reduced rigidity and bradykinesia. Bilateral stimulation improved rigidity more than unilateral stimulation of either side, but there was no significant difference between ipsilateral and contralateral stimulation. Although bilateral stimulation also increased hand rotation velocity more than unilateral stimulation of either side, contralateral stimulation increased hand rotation significantly more than ipsilateral stimulation. All stimulation conditions improved walking time but bilateral stimulation provided the greatest improvement.
CONCLUSIONS: Unilateral STN DBS decreased rigidity and bradykinesia contralaterally as well ipsilaterally. As expected, bilateral DBS improved gait more than unilateral DBS.

Entities:  

Mesh:

Year:  2008        PMID: 18329019      PMCID: PMC2413293          DOI: 10.1016/j.expneurol.2008.01.024

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  66 in total

1.  Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients.

Authors:  Antonella Pollo; Elena Torre; Leonardo Lopiano; Mario Rizzone; Michele Lanotte; Andrea Cavanna; Bruno Bergamasco; Fabrizio Benedetti
Journal:  Neuroreport       Date:  2002-08-07       Impact factor: 1.837

2.  Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging.

Authors:  Jean A Saint-Cyr; Tasnuva Hoque; Luiz C M Pereira; Jonathan O Dostrovsky; William D Hutchison; David J Mikulis; Aviva Abosch; Elspeth Sime; Anthony E Lang; Andres M Lozano
Journal:  J Neurosurg       Date:  2002-11       Impact factor: 5.115

3.  Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.

Authors:  J Xie; P Krack; A L Benabid; P Pollak
Journal:  J Neurol       Date:  2001-12       Impact factor: 4.849

4.  Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts.

Authors:  W Hamel; U Fietzek; A Morsnowski; B Schrader; J Herzog; D Weinert; G Pfister; D Müller; J Volkmann; G Deuschl; H M Mehdorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

5.  High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis.

Authors:  M Rizzone; M Ferrarin; A Pedotti; B Bergamasco; E Bosticco; M Lanotte; P Perozzo; A Tavella; E Torre; M Recalcati; A Melcarne; L Lopiano
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

6.  Unilateral subthalamic nucleus lesioning: a safe and effective treatment for Parkinson's disease.

Authors:  Osvaldo Vilela Filho; Délson José da Silva
Journal:  Arq Neuropsiquiatr       Date:  2003-01-15       Impact factor: 1.420

7.  How do parkinsonian signs return after discontinuation of subthalamic DBS?

Authors:  P Temperli; J Ghika; J-G Villemure; P R Burkhard; J Bogousslavsky; F J G Vingerhoets
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

8.  Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

Authors:  Galit Kleiner-Fisman; David N Fisman; Elspeth Sime; Jean A Saint-Cyr; Andres M Lozano; Anthony E Lang
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

9.  Subthalamic locomotor region is involved in running activity originating in the rat ventromedial hypothalamus.

Authors:  K Narita; T Murata; K Honda; M Nishihara; M Takahashi; T Higuchi
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

Review 10.  Brainstem motor loops in the control of movement.

Authors:  Dipankar Nandi; Tipu Z Aziz; Xuguang Liu; John F Stein
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

View more
  31 in total

1.  Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.

Authors:  Jay L Alberts; Claudia Voelcker-Rehage; Katie Hallahan; Megan Vitek; Rashi Bamzai; Jerrold L Vitek
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

Review 2.  The deep brain stimulation of the pedunculopontine tegmental nucleus: towards a new stereotactic neurosurgery.

Authors:  Paolo Mazzone; Stefano Sposato; Angelo Insola; Eugenio Scarnati
Journal:  J Neural Transm (Vienna)       Date:  2011-02-12       Impact factor: 3.575

3.  Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.

Authors:  Stephanie Cernera; Robert S Eisinger; Joshua K Wong; Kwo Wei David Ho; Janine Lobo Lopes; Kevin To; Samuel Carbunaru; Adolfo Ramirez-Zamora; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  NPJ Parkinsons Dis       Date:  2020-07-06

4.  Functional anatomy of subthalamic nucleus stimulation in Parkinson disease.

Authors:  Sarah A Eisenstein; Jonathan M Koller; Kathleen D Black; Meghan C Campbell; Heather M Lugar; Mwiza Ushe; Samer D Tabbal; Morvarid Karimi; Tamara Hershey; Joel S Perlmutter; Kevin J Black
Journal:  Ann Neurol       Date:  2014-07-02       Impact factor: 10.422

Review 5.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

6.  The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease.

Authors:  Lisa C Goelz; Fabian J David; John A Sweeney; David E Vaillancourt; Howard Poizner; Leonard Verhagen Metman; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2016-11-14       Impact factor: 1.972

7.  Activation of subthalamic neurons by contralateral subthalamic deep brain stimulation in Parkinson disease.

Authors:  Harrison C Walker; Ray L Watts; Christian J Schrandt; He Huang; Stephanie L Guthrie; Barton L Guthrie; Erwin B Montgomery
Journal:  J Neurophysiol       Date:  2010-12-22       Impact factor: 2.714

8.  Unilateral deep brain stimulation surgery in Parkinson's disease improves ipsilateral symptoms regardless of laterality.

Authors:  Kamal Shemisa; Chris J Hass; Kelly D Foote; Michael S Okun; Samuel S Wu; Charles E Jacobson; Yunfeng Dai; Genko Oyama; Hubert H Fernandez
Journal:  Parkinsonism Relat Disord       Date:  2011-12       Impact factor: 4.891

Review 9.  Deep brain stimulation improves gait velocity in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Jaimie A Roper; Nyeonju Kang; Juliana Ben; James H Cauraugh; Michael S Okun; Chris J Hass
Journal:  J Neurol       Date:  2016-04-28       Impact factor: 4.849

Review 10.  Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Jay L Alberts; Christopher J Hass; Jerrold L Vitek; Michael S Okun
Journal:  Exp Neurol       Date:  2008-07-31       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.